Drugs / TOPSALYSIN
TOPSALYSIN
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01454349 | Sep 2011 → Mar 2013 | benign prostatic hyperplasia | Sophiris Bio Corp | Completed | No outcome recorded |
| Phase 24 trials · 1 met primary | ||||||
| Phase 2 | NCT03081481 | Jun 2017 → Nov 2018 | prostate cancer | Sophiris Bio Corp | Completed | No outcome recorded |
| Phase 2 | NCT02499848 | Jul 2015 → Jun 2016 | prostate cancer | Sophiris Bio Corp | Completed | No outcome recorded |
| Phase 2 | NCT00889707 | Jan → Dec 2009 | benign prostatic hyperplasia | Sophiris Bio Corp | Completed | Met primary |
| Phase 2 | NCT00686088 | Feb 2008 → Sep 2009 | — | Sophiris Bio Corp | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01966614 | Oct 2013 → Dec 2015 | benign prostatic hyperplasia | Sophiris Bio Corp | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TOPSALYSIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364656 ↗ |
| Known as | PRX302 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00686088 ↗ |
| Known as | Topsalisina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364656 ↗ |
| Known as | Topsalysine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364656 ↗ |
| Route | Other | “transperineal intraprostatic injection” NCT00889707 ↗ |